Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Form 8.3 - ANT plc

18 Sep 2012 09:12

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/ The Income & Growth VCT plc dealings are being disclosed:

(b) Owner or controller of interests and short N/A positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient (c) Name of offeror/offeree in relation to ANT plc whose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: 13 September 2012 (f) Has the discloser previously disclosed, or NO are they today disclosing, under the Code in respect of any other party to this offer? If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Interests Short positions Number % Number % (1) Relevant securities owned 656,596 2.7% and/or controlled: (2) Derivatives (other than options): (3) Options and agreements to purchase/sell: TOTAL: 656,596 2.7%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in N/A relation to which subscription right exists: Details, including nature of the N/A rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit security securities -

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position -

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option relevant description purchasing, securities price

date money security e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. - (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option -

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit

security (if applicable) e.g. subscription, conversion -

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

-

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

- (c) AttachmentsIs a Supplemental Form 8 (Open Positions) attached? [DEL:YES:DEL]/ NO Date of disclosure: 18 September 2012 Contact name: Sarah Penfold Telephone number: 020 7024 7616

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk . The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Date   Source Headline
18th Jun 202511:15 amRNSChange of Name
9th Jun 202512:30 pmRNSRealisation of investment in Rota Geek Limited
2nd Jun 20257:00 amRNSRealisation of investment in My Tutorweb Limited
1st May 20257:00 amRNSTotal Voting Rights
11th Apr 20253:49 pmRNSDirector/PDMR Shareholding
11th Apr 20253:12 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSTransaction in own shares and Total Voting Rights
6th Mar 20251:23 pmRNSInterim Management Statement
5th Mar 20256:05 pmRNSResult of AGM
5th Mar 20255:17 pmRNSDividend Declaration
3rd Mar 20252:30 pmRNSTotal Voting Rights and Capital
26th Feb 20256:10 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20257:00 amRNSAnnual Financial Report
2nd Dec 20247:00 amRNSTotal Voting Rights and Capital
29th Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
18th Oct 20243:10 pmRNSDirector/PDMR Shareholding
18th Oct 20242:58 pmRNSIssue of Equity and Total Voting Rights
17th Oct 20244:26 pmRNSOFFER FOR SUBSCRIPTION - UPDATE
2nd Oct 20247:05 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
26th Sep 20242:23 pmRNSTransaction in Own Shares and Total Voting Rights
18th Sep 202410:00 amRNSOffer for Subscription – Update
12th Sep 20245:31 pmRNSInterim Management Statement
11th Sep 20244:33 pmRNSDividend Declaration
2nd Sep 20243:15 pmRNSOffers for Subscription – Open for Applications
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights and Capital
26th Jul 20243:00 pmRNSDirector/PDMR Shareholding
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:30 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:35 amRNSTotal Voting Rights
27th Jun 20248:00 amRNSDirector Declaration
18th Jun 20245:54 pmRNSPROPOSED MERGER AND OFFERS
12th Jun 20244:08 pmRNSHalf-year Report
12th Jun 202410:39 amRNSIssue of Equity and Total Voting Rights
10th Jun 20244:00 pmRNSMerger Proposals/Intention To Launch Joint Offers
7th Jun 202411:05 amRNSDirector/PDMR Shareholding
7th Jun 202410:29 amRNSIssue of Equity and Total Voting Rights
3rd Jun 20242:29 pmRNSNet Asset Value at 31 March 2024
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
9th May 202411:29 amRNSDividend Declaration - Replacement
9th May 20247:00 amRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.